Tareq Abadl/LinkedIn
Sep 4, 2026, 18:22
Tareq Abadl: The Clinical Meaning of C3 and C4
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Complement C3 vs C4 — Don’t Mix Them Up!
Confused about C3 vs C4 in Immunology?
Here’s the high-yield difference you need to remember:
- C3 is the major and central complement component.
- C4 is mainly associated with the Classical and Lectin pathways.
Clinical Pearl:
- Low C3 with normal C4 may suggest alternative pathway activation.
- Low C3 with low C4 may indicate classical pathway consumption.
ASCP / BOC Pearl:
- Don’t interpret complement levels alone.
- Always correlate C3, C4, and clinical findings.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge